GlassScriptPhysician profile
Melissa Somers
NPI 1083815559
$1,912.68
in general payments reported to CMS, 2019-2025
18 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $133 · 2021: $271 · 2022: $451 · 2023: $283 · 2024: $119 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408 · Consulting Fee: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.76 |
| Consulting Fee | $145.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $240.28 | 2019-2025 | Audion Et Dilation System |
| Medtronic, INC. | $235.74 | 2022-2024 | Straightshot, Nuvent, Propel |
| Intersect Ent, INC. | $179.19 | 2019-2021 | |
| Davol INC. | $177.29 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $168.99 | 2019-2023 | Dupixent |
| Aerin Medical INC. | $150.96 | 2019-2021 | |
| Acclarent, INC | $133.00 | 2020-2023 | Relieva Spinplus |
| Genzyme Corporation | $128.30 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $98.99 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $84.05 | 2019 | |
| Glaxosmithkline, LLC. | $80.85 | 2021-2023 | Nucala |
| Merz North America, INC. | $66.43 | 2021 | |
| Sun Pharmaceutical Industries INC. | $41.23 | 2025 | |
| Harrow Eye, LLC | $35.32 | 2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $33.55 | 2025 | Xdemvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $23.12 | 2024 | Izervay |
| Baxter Healthcare | $20.07 | 2023 | Floseal |
| Karl Storz Endoscopy-America | $15.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Somers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.